BridgeMD
New treatment option for Gait Disorders, Neurologic
Official title Home-based Gait Rehabilitation Service Using the Insole-type Gait Analysis Device for Children With Cerebral Palsy
ClinicalTrials.gov ID: NCT06461923
What this study is testing
- What it's testing
- Walking is a crucial daily activity that requires complex coordination of muscular systems. It is essential for bone and muscle health, cardiovascular fitness, and activities of daily living, making it an important indicator of prognosis and patient function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 18
You may be able to join if
- Patients diagnosed with cerebral palsy aged 7 to 18 years old
- Patients classified as Gross Motor Function Classification System level 1 or 2
- Individuals who visited Severance Hospital, comprehended the study, agreed to participate, and submitted the informed consent form
You likely can't join if
- Individuals with complications such as severe foot deformities where the sensors of the insole gait analysis device cannot be recognized
- In addition to above, individuals with clinically significant findings deemed inappropriate for this study by the study director or person in charge...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seodaemun-gu, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seodaemun-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.